share_log

Insider Sale: EVP of $ATRA (ATRA) Sells 1,000 Shares

Insider Sale: EVP of $ATRA (ATRA) Sells 1,000 Shares

內幕交易:$ATRA(ATRA)執行副總裁出售1,000股
Quiver Quantitative ·  11/20 18:16

Jill Henrich, the EVP of $ATRA ($ATRA), sold 1,000 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.9% of their shares. Following this trade, they now own 19,378 shares of $ATRA stock.

$ATRA Insider Trading Activity

$ATRA insiders have traded $ATRA stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here's a breakdown of recent trading of $ATRA stock by insiders over the last 6 months:

  • JILL HENRICH (EVP, Chief Regulatory Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 1,963 shares.
  • ERIC J HYLLENGREN (EVP, CFO and COO) has traded it 3 times. They made 0 purchases and 3 sales, selling 2,434 shares.
  • ANHCO NGUYEN (President and CEO) has traded it 4 times. They made 0 purchases and 4 sales, selling 3,485 shares.
  • PASCAL TOUCHON (President and CEO) has traded it 2 times. They made 0 purchases and 2 sales, selling 3,038 shares.
  • AMAR MURUGAN (EVP, Chief Legal Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 1,158 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ATRA Hedge Fund Activity

We have seen 0 institutional investors add shares of $ATRA stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • EVERSOURCE WEALTH ADVISORS, LLC added 0 shares (+0.0%) to their portfolio in Q3 2024
  • IFP ADVISORS, INC added 0 shares (+0.0%) to their portfolio in Q2 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論